Physician
Lyons, Michael
Lyons, Michael was paid $1.73M by Medicaid between Jan 2018 and Mar 2023, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoLYONS, MICHAEL
LEOMINSTER, MA 01453
LEOMINSTER, MA 01453
33aNPI1306834650assigned 10/11/2005
33bProvider typePediatrics Physician
28Total paid$1.73M
24GClaims38,301
24DCodes billed36
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#32 of 1,273
Median peer was paid$24K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,371 | $109K | |
| 2019 | 6,508 | $275K | |
| 2020 | 6,354 | $259K | |
| 2021 | 10,080 | $448K | |
| 2022 | 10,925 | $539K | |
| 2023 | 2,063 | $101K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 4,767 | 4,552 | $470K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 6,135 | 5,915 | $343K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.0% | 3,456 | 3,329 | $157K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.1% | 1,272 | 1,271 | $106K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 1,274 | 1,274 | $105K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.5% | 1,848 | 1,809 | $94K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.6% | 1,019 | 1,009 | $79K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.0% | 757 | 757 | $69K |
| 90461 | 2.8% | 1,451 | 1,446 | $49K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.7% | 5,185 | 5,179 | $48K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 531 | 526 | $43K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.2% | 3,599 | 3,587 | $38K |
24 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 924 | $29K |
| 92552 | <1% | 670 | $15K | |
| 96127 | <1% | 1,320 | $14K | |
| 99173 | <1% | 599 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 831 | $10K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 42 | $8K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 72 | $7K |
| 87634 | <1% | 92 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 244 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 271 | $5K |
| 87081 | <1% | 661 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 172 | $3K |
| 99051 | <1% | 122 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 60 | $2K |
| 0124A | <1% | 34 | $2K | |
| 99050 | <1% | 79 | $1K | |
| 85018 | <1% | 630 | $1K | |
| 0071A | <1% | 30 | $1K | |
| 99188 | <1% | 36 | $936.00 | |
| 0001A | <1% | 14 | $642.32 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 28 | $342.44 |
| 90688 | <1% | 12 | $132.00 | |
| 81003 | <1% | 51 | $100.98 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 13 | $3.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.